MODELLING INFLUENZA- ASSOCIATED MORTALITY USING TIME-SERIES REGRESSION APPROACH Stefan Ma, CStat, PhD Epidemiology & Disease Control.

Slides:



Advertisements
Similar presentations
Pandemic Influenza What You Need to Know Available online at: Contra Costa.
Advertisements

Will the Avian Flu Become the Next Epidemic?
Pandemic Influenza Contra Costa Health Services Public Health Division June 2006.
Prepared by Dr Alissar Rady, WHO Lebanon
AMMI Canada /CPHA Co-developed Accredited Learning Activity December 3, 2014 Dat Tran, MD, MSc Staff Physician, Division of Infectious Diseases The Hospital.
Swine flu.
The pandemic and a brief ABC of influenza Thomas Abraham JMSC 6090.
Influenza and Influenza Vaccine
Influenza Outbreaks and Cruise Ships Laura Martin 25 April 2002.
Avian Influenza – The Bird Flu
INFLUENZA. VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks.
 Refers to an illness caused by any of many different strains of influenza viruses that have adapted to a specific host.  It considers as a flu.  You.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
DISEASE AND PANDEMICS Brijesh Patel.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
ABCs of Influenza and Pandemics
By Andrew Garaniel University of California, Irvine
Avian and Pandemic Influenza Kathy Harriman Minnesota Department of Health Infectious Disease Prevention and Control Division Acute Disease Epidemiology.
Influenza Ieuan Davies. Signs and Symptoms Influenza is an acute, viral respiratory infection. Fever, chills, headache, aches and pains throughout the.
Influenza Highly infectious viral illness First pandemic in 1580 At least 4 pandemics in 19th century Estimated 21 million deaths worldwide in pandemic.
Pandemic Preparedness: Planning for Business Continuity, Productivity, and Resilience Rick Allen, PhD Peter Wald, MD, MPH September
Someday in the Spring, an Army private reported to the camp hospital before breakfast. He had a fever, sore, throat, headache... nothing serious. One minute.
Influenza Vaccination
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Pandemic influenza planning tool kit for business/employers, dev'd spring PREPARING FOR AN INFLUENZA PANDEMIC.
Epidemic Vs Pandemic 8.L.1.2.
INTRODUCTION TO INFLUENZA The (Ferret) Sneeze Heard Around The World: The Case Of The Bioengineered Bird Flu Case Study for AAC&U STIRS Project Jill M.
EPIDEMIOLOGY AND PREVENTION OF INFLUENZA. Introduction Unique epidemiology: – Seasonal attack rates of 10% to 30% – Global epidemics Influenza viruses.
20 Answers About Influenza
EPIDEMIOLOGY AND PREVENTION OF INFLUENZA. Introduction Unique epidemiology: – Seasonal attack rates of 10% to 30% – Global pandemics Influenza viruses.
Philadelphia Actuaries Club Pandemics – Past, Present and Future Presented by Annemarie Brownmiller Consulting Services of Princeton, LLC 19 November 2009.
TANEY COUNTY HEALTH DEPARTMENT AUGUST 2009 Situation Update: H1N1 Influenza A.
Pandemic Influenza; A Harbinger of Things to Come Michael T Osterholm PhD, MPH Director, Center for Infectious Disease Research and Policy Associate Director,
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.
Influenza What is it?. Influenza Virus Understanding Terminology Epidemic: serious outbreak in a single community, population or region Pandemic: epidemic.
Wavelets and excess disease models for analysis of time series data Dan Weinberger Fogarty International Center National Institutes of Health.
Epidemiology of Influenza. The Flu Basics The flu is contagious and can range from mild to deadly Each year between 5% and 20% of the US population contracts.
Influenza of 1918 Danielle Albin Dane van Loon Matthew Litch.
Influenza Today Joseph Mester, Ph.D. September 24, 2009.
What do you need to know? Are you at risk? How do you protect yourself? SWINE FLU Partnership for Environmental Education and Rural Health peer.tamu.edu.
Pandemic Influenza: What Is It and Why Should We Care? Dr. Judith A. Monroe, MD State Health Commissioner.
1 Using ESSENCE-FL and a serosurvey to estimate total influenza infections, 2009 Richard S. Hopkins, MD, MSPH Kate Goodin, MPH Mackenzie Weise, MPH Aaron.
Avian Influenza H5N1 Prepared by: Samia ALhabardi.
Influenza Influenza Virus magnified 100,000X. What is Influenza? Virus; causes chills, fever, sore throat, fatigue.
Dr A.J.France. Ninewells Hospital © A.J.France 2010.
William W. Thompson, PhD Immunization Safety Office Office of the Chief Science Officer Centers for Disease Control and Prevention Impact of Seasonal Influenza.
1 Division of Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO) Fifth Meeting of National Influenza Centres in the Western.
Influenza biology and epidemiology. The course of illness  Symptoms  Fever, headache, body aches, fatigue  Cough, sore throat, runny nose  Duration:
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
INFLUENZA LUKE UYEMURA ENGLISH 100 ESP. BASIC INFO Definition: Influenza, more commonly know as the flu, is a viral infection that attacks your respiratory.
Influenza. n Begins abruptly n 20% to 50% of population affected n Complications can develop n Enter thru mucous membranes of eyes, nose or mouth n Contagious.
PROJECT MANAGEMENT Influenza Annual Update Weesp, February Dorine Leyssius.
Epidemiology of Swine Influenza H1N1 Amman 5/5/2009 Dr. Labib Sharif Associate Prof. Of Epidemiology Faculty of Veterinary Medicine Jordan University of.
Agilent Restricted Influenza H1N1 A (Swine Influenza) Information for Agilent’s Employees.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
To Dear Staff and Students The prevention of respiratory tract disease----- influenza The prevention of respiratory tract disease----- influenza.
Influenza and Influenza Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
CVD Testing the H1N1 Pandemic Flu Vaccines Mini-Med School Karen Kotloff, MD University of Maryland School of Medicine Center for Vaccine Development September.
Preparing for Pandemic Flu Algean Garner II, Psy.D. Director, Health and Human Services Village of Hoffman Estates.
INFLUENZA Causes of influenza: Influenza viruses A, and B RSV and adenovirus Mycoplasma pneumoniae Chlamydia species.
I Introduction to influenza
I Introduction to influenza Department of Health 2016 Vaccination Campaign Training workshop Presentation developed by the National Institute for Communicable.
Will it be just a scare … or a scar on human history? Bird flu.
Seasonal Influenza and Pandemic Influenza A (H1N1, H5N1) Virus Dr. Alaa kuttar musa Department of Medicine College of Medicine/ Basra University.
Influenza Vaccines MedCh 401 Lecture 5 19May06 KL Vadheim Lecture 4.
Establishment of Influenza Surveillance System in Liberia
وبائية أنفلونزا الطيور والإجراءات المتخذة لمواجهة الوباء العالمي
دانشگاه علوم پزشکی کرمانشاه حوزه معاونت امور بهداشتی آذرماه 1394
Craig Conlon MD, PhD, Employee Health Services Northern California
Presentation transcript:

MODELLING INFLUENZA- ASSOCIATED MORTALITY USING TIME-SERIES REGRESSION APPROACH Stefan Ma, CStat, PhD Epidemiology & Disease Control Division Ministry of Health, Singapore Taiwan Hsinchu Workshop on Mathematical Modeling of Infectious Disease (May 31- June 1, 2006)

Background n Influenza virus infections cause excess morbidity and mortality in temperate countries. n In the Northern and Southern Hemisphere, influenza epidemics occur nearly every winter, leading to an increase in hospitalization and mortality. n However, little is known about the disease burden of influenza in tropical regions, e.g. Singapore, where the effect of influenza is thought to be less.

Epidemiology of Influenza n Highly infectious viral illness n Epidemics reported since at least 1510 n At least 4 pandemics in 19th century n Estimated 21 million deaths worldwide in pandemic of n Virus first isolated in 1933

Influenza Virus A/Moscow/21/99 (H3N2) Neuraminidase Hemagglutinin Type of nuclear material Virus type Geographic origin Strain number Year of isolation Virus subtype

Influenza Virus n Single-stranded RNA virus n Family Orthomyxoviridae n 3 types: A, B, C n Subtypes of type A determined by hemagglutinin and neuraminidase

Influenza Virus Strains n Type A- moderate to severe illness - all age groups - humans and other animals n Type B- milder epidemics - humans only - primarily affects children n Type C- rarely reported in humans - no epidemics

n Structure of hemagglutinin (H) and neuraminidase (N) periodically change n ShiftMajor change, new subtype Exchange of gene segment May result in pandemic n DriftMinor change, same subtype Point mutations in gene May result in epidemic Influenza Antigenic Changes

Examples of Influenza Antigenic Changes n Antigenic shift: u H2N2 circulated in u H3N2 appeared in 1968 and completely replaced H2N2 n Antigenic drift u In 1997, A/Wuhan/359/95 (H3N2) virus was dominant u A/Sydney/5/97 (H3N2) appeared in late 1997 and became the dominant virus in 1998

Influenza Type A Antigenic Shifts Year Subtype H3N2 H1N1 H2N2 H3N2 H1N1 Severity of Pandemic Moderate Severe Moderate Mild

Influenza Pandemics in History 1918 ‘Spanish’ flu 1957 ‘Asian’ flu 1968 ‘Hong Kong’ flu 2 At least two pandemics originated from Asia

Impact of Pandemic Influenza n 200 million people could be affected n Up to 40 million require outpatient visits n Up to 700,000 hospitalized n 89, ,000 deaths

Influenza Self-limiting and minor symptoms: sudden onset, fever, headache, muscle pain, dry cough, sore throat Transmitted through droplets Possible serious complications, such as pneumonia and cerebrovascular diseases

Objectives n To examine the influenza-associated mortality in tropical Singapore using time-series regression approach

Population attributable fraction (risk) or burden For a dichotomous (harmful) exposure Proportion that would not have occurred with zero exposure (e.g., smoking status). But Needs also to be generalized to continuous exposures (e.g., blood pressure level); and To preventive exposures e.g., physical activity.

Population attributable fraction (risk) or burden For a dichotomous case, the following formula will be usually used: where p is the exposed prevalence, RR is the relative risk of exposed (vs non-exposed). Special case if 100% exposed prevalence is assumed:

Generalising to preventive exposures For a dichotomous protective exposure Proportion of the cases that would have occurred in the absence of exposure that were prevented by the exposure Note: denominator is the hypothetical total applying in the ‘unprotected’ counterfactual EG for moderate alcohol drinking and IHD Prevented fraction = Prevented cases /Total expected in counter- factual non-drinking population

Population attributable fraction (risk) or burden Generalising to continuous exposures attributable burden = difference between burden currently observed and what would have been observed under a (past) counterfactual exposure distribution

Problems encountered n But, all these exposure data are measured at the individual levels that are collected using individual-based study design. n There is problem in studying impacts of influenza in human setting! u Because of no individual exposure data available.

Possible solution n Epidemiological time-series data using regression approach could help?!

Two State-of-the-art methods: 1. Comparative method: u The average numbers of deaths or hospital admissions during the months assumed to have low or no influenza virus circulation are defined, followed by calculation of the excess mortality or hospitalization by subtracting this baseline from the observed numbers of deaths or hospital admissions during influenza epidemics.

Source: Chiu et al. NEJM 2002;347:

Two State-of-the-art methods: 2. Regression method developed by Serfling: u First sets a baseline for excess numbers of events by fitting a linear regression function to the data of the period assumed to have a low virus circulation, after taking into consideration the confounding factors such as seasonality and meteorological condition without including influenza virus data in the model.

Two State-of-the-art methods: 2. Regression method developed by Serfling (cont’d): u used to assess impact on hospitalization, but only in temperate countries where there are well- established and clear seasonal patterns of influenza.

Source: Griffin and Neuzil. NEJM 2002;347:

Short-coming of these 2 methods: n Application of either comparative or Serfling methods requires a well- defined seasonal pattern of non- influenza period. n Required alternative approach!

% of specimens positive for influenza Weekly percentages of specimen positive for influenza in Hong Kong Human influenza epidemics occur almost every year Source: Wong et al. CID 2004;39:

Influenza in the Tropics and Subtropics Lack of well-defined seasonality: influenza peaks usually appear during winter and spring Influenza virus isolation rates in Singapore during

Viboud et al. PoLS Medicine 2006;3:e89.

Methods and Materials n Monthly counts of all-cause mortality, underlying cause-specific deaths for cardiovascular & respiratory (C&R) and pneumonia & influenza (P&I) occurred in Singapore during 1996—2003 were studied. n Monthly percentages of influenza A sub-types (H1N1, H3N2), influenza B and respiratory syncytial virus positive tested in the same period were also used for analysis. n The impact of influenza on mortality adjusted for number of days for each month, trends, seasonal patterns, temperature and relative humidity and over-dispersion were estimated from negative binomial regression models.

Statistical models

Epidemic models Mass-action assumption  and  are the mixing parameters

Statistical models In statistics, excess risk is the increase of risk relative to some baseline risk. excess risk = ( 1 - relative risk ) * 100 %

Statistical models

Excess deaths were estimated by difference between observed and predicted deaths observed deaths — fitted values by modeling Excess deaths Source: Wong et al. CID 2004;39:

Annual influenza viruses and respiratory syncytial virus (RSV) surveillance data in Singapore,

Annual mortality in Singapore,

Adjusted risk ratios* (95% confidence intervals) and p-values for each 10% change in positive influenza A and RSV tests, and for each 1% change in positive influenza B† tests respectively, estimated by negative binomial regression model, (regardless of testing method for respiratory specimens)

Adjusted risk ratios* (95% confidence intervals) and p-values for each 10% change in positive influenza A and RSV tests, and for each 1% change in positive influenza B† tests respectively, estimated by negative binomial regression model,

Estimated influenza-associated excess mortality in Singapore,

Annual influenza-associated mortality in Singapore, Hong Kong and United States.

Summary of the findings n Influenza A (H3N2) was the predominant circulating influenza virus subtype, with consistently significant and robust effect on mortality. n Influenza was associated with an annual mortality from all causes, from underlying P&I, and from underlying C&R conditions of 14.8 (95% confidence interval 9.8–19.8), 2.9 (1.0–5.0), and 11.9 (8.3– 15.7) per 100,000 person-years, respectively. n These results are comparable with observations in the United States and subtropical Hong Kong. n An estimated 6.5% of underlying P&I deaths was attributable to influenza. The proportion of influenza- associated mortality was 11.3 times higher in persons age >65 years than in the general population

Conclusions n Time-series regression approach is a good alternative compared with two current methods. n In our study, significant burden associated with influenza activities was showed using this alternative approach. n Our findings support the need for influenza surveillance and annual influenza vaccination for at risk population in tropical countries

Thank You